Clinical Trial Update: Study to Test the Effectiveness of Controlled-Release OROS® Hydromorphone HCl Compared to Placebo in Patients With Chronic Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating controlled-release hydromorphone for chronic low back pain has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Controlled-Release OROS Hydromorphone HCl (hydromorphone)

Snippet

Sponsor: Mallinckrodt | Conditions: Chronic Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-06-17